Topic - Glaxosmithkline

Subscribe to this topic via RSS or ATOM
Related Stories
  • FILE - In this July 24, 2013 file photo, a Chinese flag is hoisted in front of a GlaxoSmithKline building in Shanghai, China. Police accused a British executive of drug maker GlaxoSmithKline on Wednesday, May 14, 2014, of leading a sprawling scheme to bribe doctors and hospitals to use its products. (AP Photo/Eugene Hoshiko, File)

    British executive accused in China drug bribery

    Chinese police Wednesday accused a British executive of GlaxoSmithKline of leading a sprawling scheme to bribe doctors and hospitals to use its drugs.

  • Drug recalled after foreign pills found in bottles

    GlaxoSmithKline is recalling the weight loss drug Alli after receiving reports of unknown pills and tablets in the bottles.

  • Pharma data play larger role in Olympic drug tests

    Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this year's Winter Olympics: They're providing information on drugs that once would have been considered proprietary trade secrets.

  • China accuses drugmaker GlaxoSmithKline of bribery, fraud

    China has accused British-based big pharm GlaxoSmithKline of offering bribes and kickbacks in order to boost sales across the country.

  • GlaxoSmithKline to pay $3B for health fraud

    British drugmaker GlaxoSmithKline will pay $3 billion in fines _ the largest health care fraud settlement in U.S. history _ for criminal and civil violations involving 10 drugs that are taken by millions of people.

  • Justices deny drug salesmen overtime

    The Supreme Court has ruled that sales representatives for pharmaceutical companies do not qualify for overtime pay under federal law, a big victory for the drug industry.

  • An Anopheles funestus mosquito, which spreads a deadly malaria parasite common in sub-Saharan Africa, sucks blood from a human host. A malaria vaccine tested in seven African countries cut the number of malaria cases in young children in half. More studies need to be done, including on infants. (University of Notre Dame via CDC via Associated Press)

    Vaccine halves malaria in children

    The quest for the world's first malaria vaccine appears to have taken a big step: A study in Africa shows experimental shots cut the risk of disease in young children by half.

  • FDA reviews 2 new drugs to reduce prostate cancer

    Health regulators say two drugs from GlaxoSmithKline and Merck reduce the risk of prostate tumors in men, though scientists complain the companies only studied a small number of African Americans, who are at high risk for prostate cancer.

  • Michigan AG: State to get $4.7M from drug case

    Michigan Attorney General Mike Cox says the state will get a $4.7 million share of a $750 million settlement of claims that GlaxoSmithKline distributed adulterated drugs.

  • Timeline of events for diabetes pill Avandia

    U.S. health regulators dealt a major blow to the controversial diabetes pill Avandia Thursday, requiring doctors and patients to sign consent forms before starting a prescription of the drug. At the same time, European regulators ordered it off the market. The split decision underscores lingering safety questions about a once-blockbuster drug taken by millions of patients over the last decade.

  • A pharmacist holds a bottle of Avandia pills at Maximart Pharmacy in Palo Alto, Calif., on Wednesday, June 30, 2010. (AP Photo/Paul Sakuma)

    FDA restricts, EU bans Avandia diabetes pill

    European regulators ordered the diabetes drug Avandia off the market, and the Food and Drug Administration placed stringent restrictions on its use in the United States, saying heart attack risks associated with the former blockbuster are too great a safety concern to continue its use for most people.

  • Diabetes drug off market in Europe

    European regulators ordered the diabetes drug Avandia off the market and the Food and Drug Administration placed stringent restrictions on its use in the United States, saying heart attack risks associated with the former blockbuster are too great a safety concern to continue its use for most people.

  • FDA keeps diabetes pill with heart risks on market

    Federal health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.

  • US restricts, EU bans controversial diabetes pill

    European regulators ordered the diabetes drug Avandia off the market and the Food and Drug Administration placed stringent restrictions on its use in the United States, saying heart attack risks associated with the former blockbuster are too great a safety concern to continue its use for most people.

  • Spiriva as good as Serevent in asthma study

    Researchers say they've found a possible new treatment for adults with hard-to-control asthma. Their discovery, however, came at a price.

More Stories →

Happening Now